DIAGNOS Inc. (OTCMKTS:DGNOF – Get Free Report)’s stock price was up 33.4% during mid-day trading on Tuesday . The stock traded as high as $0.23 and last traded at $0.2001. 64,990 shares traded hands during mid-day trading, a decline of 46% from the average daily volume of 120,684 shares. The stock had previously closed at $0.15.
DIAGNOS Trading Up 0.8%
The firm has a market cap of $24.21 million, a price-to-earnings ratio of -5.00 and a beta of -0.09. The business has a fifty day moving average of $0.16 and a two-hundred day moving average of $0.19. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.49 and a current ratio of 1.49.
DIAGNOS (OTCMKTS:DGNOF – Get Free Report) last released its quarterly earnings results on Thursday, June 11th. The company reported ($0.01) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.01). The firm had revenue of $0.01 million for the quarter, compared to analyst estimates of $0.05 million.
About DIAGNOS
DIAGNOS Inc provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence.
Further Reading
- Five stocks we like better than DIAGNOS
- Microsoft Just Flipped the AI Spending Narrative Overnight
- Qualcomm’s Turnaround Is Working, So Why Is Wall Street Selling?
- Meta’s Earnings Show Why Wall Street Is Losing Patience With AI Spending
- Can Starbucks Keep This Turnaround Going? The Latest Results Say Yes
Receive News & Ratings for DIAGNOS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DIAGNOS and related companies with MarketBeat.com's FREE daily email newsletter.
